Pfizer tries to vent off overbought saturation - Analysis - 11-10-2018

Pfizer's stock fell in the intraday levels, recording a loss of 2.11% in the last session, or 0.96 points, as traders collected recent short-term profits, while the stock vented off overbought saturation in the RSI, accompanied by a surge in trading volumes, with positive support from the 50-day SMA. 

We expect more correctional losses, especially if the support of 44.45 was breached, targeting the next one at 42.77. 

Expected trend for today: Bearish